HIV: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

  NCT07637669· National Institute on Drug Abuse (NIDA)· Source

• Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya

  NCT07468695· Fred Hutchinson Cancer Center· Source

• PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

  NCT04926922· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

  NCT02494986· Janssen Sciences Ireland UC· Source

• Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

  NCT07637942· International Maternal Pediatric Adolescent AIDS Clinical Trials Group· Source

• Natural History Study of Kaposi Sarcoma

  NCT06375122· National Cancer Institute (NCI)· Source

• Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

  NCT07390916· Fred Hutchinson Cancer Center· Source

• Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

  NCT07645378· Fred Hutchinson Cancer Center· Source

• Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

  NCT07645352· Fred Hutchinson Cancer Center· Source

• Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

  NCT05470491· National Cancer Institute (NCI)· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• CRISPR-Cas Systems 2
• Gene Expression Profiling 9
• Sequence Analysis, RNA 1
• Proteomics 6
• Metabolomics 1
• Mass Spectrometry 12
• Flow Cytometry 19
• Immunohistochemistry 7
• Xenograft Model Antitumor Assays 3
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 10
• Machine Learning 2
• Cohort Studies 128
• Genome-Wide Association Study 3

See which targets of this disease your abstract mentions, and go to the people working on them.